-
Institute for Molecular and Computational Medicine (IMCM). You will test GSK assets and targets in established models of podocyte and mesangial cell pathology relevant to glomerular diseases. You will
-
this hydrogen generation model with the ammonia synthesis module. Find out more about the Hayward research and group at: https://www.chem.ox.ac.uk/people/mike-hayward. About you Applicants must hold a
-
technologies have exploded in recent years, generating multi-dimensional data from millions of cells and thousands of molecular features. Understanding these data and harnessing their insights remains an ongoing
-
with cutting-edge models and technologies—including patient-derived glioblastoma organoids, CRISPR-based screens, mass cytometry, and advanced microscopy—to dissect these complex biological processes
-
. Keith Channon – a 5 year renewable award that underpins the work of the group. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of
-
analysis and is increasingly used in cancer research to uncover morphological features linked to disease pathology and severity. Similarly, molecular profiling through ‘omics technologies has provided new
-
analyze the resulting datasets using biophysical modelling. A willingness to learn and employ biochemical approaches and interact with external collaborators in molecular biology and biochemistry